Cerebral microemboli in patients with antiphospholipid syndrome

Lupus

Volumn 6, Issue 8, 1997, Pages 638-644

  Specker, Ch ^a,b   Rademacher, J ^a   Sohngen D ^a   Sitzer, M ^a   Janda, I ^a   Siebler, M ^a   Steinmetz, H ^a   Schneider, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Rheumazentrum Dusseldorf H   (Germany)

Author keywords

Antiphospholipid syndrome; Cerebrovascular ischaemia; Microemboli; SLE

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030667630     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600804     Document Type: Article

References (35)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.
2. Harris EN et al. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47-51.
3. The Antiphospholipid Antibodies in Stroke Study Group (APASS). Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischaemia. Stroke 1990; 21: 1268-1273.
4. Nencini P et al. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischaemia. Stroke 1992; 22: 189-193.
5. Levine SR, Brey RL. Neurological aspects of the antiphospholipid antibody syndrome. Lupus 1996; 5: 347-353
6. Meroni PL, Rivolta R, Ghidoni P. Histopathological findings in cases of systemic lupus erythematosus-associated antiphospholipid syndrome. Clin Rheumatol 1991; 10: 211-214.
7. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus 1996; 5: 368-371.
8. Alarcon-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. Medicine 1989; 68: 353-356.
9. Long AA et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66: 520-524.
10. Horbach DA et al. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996; 76: 916-924.
11. Brey RL Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994; 3: 299-302.
12. Toubi E et al. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
13. Piette JC. Diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a 'mission impossible'? Lupus 1996; 5: 354-363.
14. Khamashta MA et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.
15. Spencer MP et al. Detection of middle cerebral artery emboli during carotid artery endarterectomy using transcranial Doppler ultra-sonography. Stroke 1990; 21: 415-423.
16. Siebler M, Sitzer M, Steinmetz H. Detection of intracranial emboli in patients with symptomatic extracranial carotid artery disease. Stroke 1992; 23: 1652-1654.
17. Markus H. Transcranial Doppler detection of circulating cerebral emboli: a review. Stroke 1993; 24: 1246-1250.
18. Siebler M et al. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid stenosis. Neurology 1994; 44: 615-618.
19. Siebler M et al. Cerebral microembolism and the risk of ischaemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995; 26: 2184-2186.
20. Sitzer M et al. Cerebral microembolism in patients with Sneddon's syndrome. Arch Neural 1995; 52: 271-275.
21. Aaslid R, Markwalder T, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal arteries. J Neurosurg 1982; 60: 37-41.
22. Siebler M et al. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: event rates before and after carotid endarterectomy. Brain 1993; 116: 1005-1015.
23. Siebler M et al. Real-time identification of cerebral microemboli with US feature detection by a neural network. Radiology 1994; 192: 739-742.
24. Markus H et al. How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke 1996; 27: 1249-1252.
25. Khamashta MA et al Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335 1541-1544.
26. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424-1430.
27. Harris EN. The antiphospholipid syndrome. Diagnosis, management, and pathogenesis. Clin Rev Allergy Immunol 1995; 13: 39-48.
28. Lockshin MD. Antiphospholipid antibody: future developments. Lupus 1994; 4: 309-311.
29. Koike T. Anti β2-glycoprotein I antibody: specificity and clinical significance. Lupus 1996; 5: 378-380.
30. Simantov R et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
31. Lockshin MD. Pathogenesis of the antiphospholipid antibody syndrome. Lupus 1996; 5: 404-408.
32. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996; 5: 442-447.
33. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelism with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75: 536-541.
34. Warkentin TE et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691-3699.
35. Rademacher J et al. Association between microembolic Doppler signals and cerebral symptoms in patients with systemic lupus erythematosus (submitted for publication).